Cargando…

The Role of NK Cells in EBV Infection and EBV-Associated NPC

A vast majority of the population worldwide are asymptomatic carriers of Epstein-Barr Virus (EBV). However, some infected individuals eventually develop EBV-related cancers, including Nasopharyngeal Carcinoma (NPC). NPC is one of the most common EBV-associated epithelial cancers, and is highly preva...

Descripción completa

Detalles Bibliográficos
Autores principales:	Png, Yi Tian, Yang, Audrey Zhi Yi, Lee, Mei Ying, Chua, Magdalene Jahn May, Lim, Chwee Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918975/ https://www.ncbi.nlm.nih.gov/pubmed/33671917 http://dx.doi.org/10.3390/v13020300

Ejemplares similares

Emodin Inhibits EBV Reactivation and Represses NPC Tumorigenesis
por: Wu, Chung-Chun, et al.
Publicado: (2019)

EBV reactivation as a target of luteolin to repress NPC tumorigenesis
por: Wu, Chung-Chun, et al.
Publicado: (2016)

EBV and the Pathogenesis of NK/T Cell Lymphoma
por: Montes-Mojarro, Ivonne A., et al.
Publicado: (2021)

The Role of EBV-Encoded LMP1 in the NPC Tumor Microenvironment: From Function to Therapy
por: Lo, Angela Kwok-Fung, et al.
Publicado: (2021)

EBV-associated NK and T-cell lymphoid neoplasms
por: Kimura, Hiroshi, et al.
Publicado: (2022)

EBV-Positive T/NK-Cell Lymphoproliferative Disease of Childhood
por: Hong, Mineui, et al.
Publicado: (2013)

Overview of EBV-Associated T/NK-Cell Lymphoproliferative Diseases
por: Kimura, Hiroshi, et al.
Publicado: (2019)

EBV induces persistent NF-κB activation and contributes to survival of EBV-positive neoplastic T- or NK-cells
por: Takada, Honami, et al.
Publicado: (2017)

Molecular screening for Epstein Barr virus (EBV) among Sudanese patients with nasopharyngeal carcinoma (NPC)
por: Ahmed, Hussain Gadelkarim, et al.
Publicado: (2015)

Correction: EBV induces persistent NF-κB activation and contributes to survival of EBV-positive neoplastic T- or NK-cells
por: Takada, Honami, et al.
Publicado: (2017)

EBV Chronic Infections
por: Eligio, Pizzigallo, et al.
Publicado: (2010)

The role of EBV-encoded miRNA in EBV-associated gastric cancer
por: Liu, Ting, et al.
Publicado: (2023)

Transcriptional profiling of Epstein–Barr virus (EBV) genes and host cellular genes in nasal NK/T-cell lymphoma and chronic active EBV infection
por: Zhang, Y, et al.
Publicado: (2006)

Extranodal NK/T-Cell Lymphomas: The Role of Natural Killer Cells and EBV in Lymphomagenesis
por: Saleem, Atif, et al.
Publicado: (2020)

Challenges in Managing EBV-Associated T- and NK-Cell Lymphoproliferative Diseases
por: Sato, Yoshitaka
Publicado: (2018)

The Role of NK Cells in EBV Infection and Related Diseases: Current Understanding and Hints for Novel Therapies
por: Desimio, Maria G., et al.
Publicado: (2023)

Extranodal NK/T-cell lymphoma, nasal type without evidence of EBV infection
por: Wang, Wei, et al.
Publicado: (2020)

Curcuminoids as EBV Lytic Activators for Adjuvant Treatment in EBV-Positive Carcinomas
por: Ramayanti, Octavia, et al.
Publicado: (2018)

Development of a risk classification system combining TN-categories and circulating EBV DNA for non-metastatic NPC in 10,149 endemic cases
por: Chen, Fo-Ping, et al.
Publicado: (2021)

Characterization of the humoral immune response to the EBV proteome in extranodal NK/T-cell lymphoma
por: Liu, Zhiwei, et al.
Publicado: (2021)

EBV & lymphoma
por: Caballero, Dolores
Publicado: (2019)

EBV and Lymphomagenesis
por: Sausen, Daniel G., et al.
Publicado: (2023)

New concepts in EBV-associated B, T, and NK cell lymphoproliferative disorders
por: Quintanilla-Martinez, Leticia, et al.
Publicado: (2022)

EBV-induced T-cell responses in EBV-specific and nonspecific cancers
por: Zhang, Qiuting, et al.
Publicado: (2023)

N(6)‐methyladenosine‐binding protein YTHDF1 suppresses EBV replication and promotes EBV RNA decay
por: Xia, Tian‐Liang, et al.
Publicado: (2021)

Frequent traces of EBV infection in Hodgkin and non-Hodgkin lymphomas classified as EBV-negative by routine methods: expanding the landscape of EBV-related lymphomas
por: Mundo, Lucia, et al.
Publicado: (2020)

The EBV Gastric Cancer Resource (EBV-GCR): A Suite of Tools for Investigating EBV-Associated Human Gastric Carcinogenesis
por: Salnikov, Mikhail Y., et al.
Publicado: (2023)

EBV-requisitioning physicians’ guess on fatigue state 6 months after acute EBV infection
por: Asprusten, Tarjei Tørre, et al.
Publicado: (2019)

Correction: Frequent traces of EBV infection in Hodgkin and non-Hodgkin lymphomas classified as EBV-negative by routine methods: expanding the landscape of EBV-related lymphomas
por: Mundo, Lucia, et al.
Publicado: (2020)

EBV-Mir-BART5-5p targets p53 independent pathway in cytoplasm: Potential role in EBV lymphomagenesis
por: Wang, Wei-Ting, et al.
Publicado: (2022)

F factor plasmid-mediated Epstein-Barr virus genome introduction establishes an EBV positive NPC cell model
por: Duan, Jingling, et al.
Publicado: (2019)

EBV-Positive Lymphoproliferations of B- T- and NK-Cell Derivation in Non-Immunocompromised Hosts
por: Dojcinov, Stefan D., et al.
Publicado: (2018)

Clinical analysis of 42 cases of EBV-positive mature T/NK-cell neoplasms
por: Yang, Haiyan, et al.
Publicado: (2017)

Non-EBV-Related Aggressive NK-Cell Leukemia: An Oncohematological Great Imitator
por: Lepe-Zuniga, Jose L., et al.
Publicado: (2018)

Innate immune modulation in EBV infection
por: Ning, Shunbin
Publicado: (2011)

EBV in Hodgkin Lymphoma
por: Massini, Giuseppina, et al.
Publicado: (2009)

EBV and human cancer
por: Ko, Young-Hyeh
Publicado: (2015)

Antiviral Drugs for EBV
por: Pagano, Joseph S., et al.
Publicado: (2018)

Progress in EBV Vaccines
por: van Zyl, Dwain G., et al.
Publicado: (2019)

From Anti-EBV Immune Responses to the EBV Diseasome via Cross-reactivity
por: Kanduc, Darja, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hqtb38ptaa92h0ssf9jqv74nge